Completed PHASE2 INTERVENTIONAL NCT00060957

Botulinum Toxin (BOTOX) for Cerebral Palsy

Botulinum Toxin for Spasticity in Cerebral Palsy

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions Cerebral Palsy Muscle Spasticity

Updated 5 times since 2017 Last updated: Sep 23, 2016 Started: Jul 31, 1997 Primary completion: Jun 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cerebral Palsy and Muscle Spasticity and is currently completed. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Data source: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States